Literature DB >> 7426960

Computed tomography as an adjunct to bimanual examination for staging bladder tumours.

M J Kellett, R T Oliver, J E Husband, I K Fry.   

Abstract

Computed tomography (CT scanning) has been undertaken in 51 patients with bladder tumours, 15 of whom subsequently had pathological examination of the bladder to confirm the extent of tumor spread. Concordance between the CT and pathological staging (80%) was as good as that between clinical and pathological staging (73%). Most of the inaccuracies of clinical staging were underestimations of the extent of muscle invasion, whilst the inaccuracy of CT involved overstaging. The principal areas where CT might improve the accuracy of clinical staging are in patients with invasive tumours who after transurethral resection have no mass palpable on bimanual examination, and in patients following radiotherapy who might be candidates for salvage cystectomy but in whom assessment of the spread of tumour is difficult because of post-irradiation fibrosis. Data from a much larger series are required to ascertain whether the additional information provided by CT will produce any improvement in patient management.

Entities:  

Mesh:

Year:  1980        PMID: 7426960     DOI: 10.1111/j.1464-410x.1980.tb02938.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

Review 1.  Evaluation of imaging methods in the diagnosis of vesical tumours.

Authors:  J Rózsahegyi; P Magasi
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

2.  Bimanual palpation for staging of bladder cancer-clinical use and its predictors.

Authors:  Lukasz Bialek; Slawomir Poletajew; Piotr Maciej Magusiak; Mikolaj Ostrach; Jakub Szpernalowski; Bartosz Dybowski; Piotr Radziszewski
Journal:  Turk J Urol       Date:  2018-11-21

Review 3.  Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT.

Authors:  J O Barentsz; G J Jager; J A Witjes; J H Ruijs
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.